Location History:
- Vienna, AT (2015)
- Zeiselmauer-Wolfpassing, AT (2018)
Company Filing History:
Years Active: 2015-2018
Title: Christina Schellenbacher: Innovator in HPV Vaccine Development
Introduction
Christina Schellenbacher is a prominent inventor based in Zeiselmauer-Wolfpassing, Austria. She has made significant contributions to the field of vaccine development, particularly in the area of human papillomavirus (HPV) vaccines. With a total of 2 patents to her name, her work is paving the way for advancements in public health.
Latest Patents
One of her latest patents focuses on papillomavirus-like particles (VLP) as broad-spectrum human papillomavirus (HPV) vaccines. This invention involves a virus-like particle composition assembled from a chimeric polypeptide that includes the L1 major capsid protein of the papillomavirus. The composition also features a surface-displayed peptide that contains a neutralizing epitope of the papillomavirus L2 protein. The patent describes vaccine compositions that utilize these VLPs, methods for inducing an immune response against papillomavirus, and kits designed for administering the vaccine.
Career Highlights
Christina Schellenbacher is affiliated with The Johns Hopkins University, where she continues her research and development efforts. Her work is instrumental in advancing the understanding and treatment of HPV, which is a significant public health concern worldwide.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Richard B S Roden and Reinhard Kirnbauer. These partnerships have enhanced her research and contributed to the success of her innovations.
Conclusion
Christina Schellenbacher's contributions to HPV vaccine development highlight her role as a leading inventor in the field. Her innovative work is crucial for improving public health outcomes related to HPV.